Nuveen Asset Management, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$4,327,671
-26.2%
225,165
-2.4%
0.00%0.0%
Q2 2023$5,866,122
+70220.3%
230,7680.0%0.00%
-33.3%
Q1 2023$8,342
+25.3%
230,768
+37.3%
0.00%0.0%
Q4 2022$6,657
-99.9%
168,121
+26.4%
0.00%0.0%
Q3 2022$6,200,000
+3.2%
133,049
-3.0%
0.00%
+50.0%
Q2 2022$6,010,000
-36.8%
137,135
-3.3%
0.00%
-33.3%
Q1 2022$9,509,000
+12.1%
141,831
+35.8%
0.00%0.0%
Q4 2021$8,486,000
-85.1%
104,477
-78.7%
0.00%
-83.3%
Q3 2021$57,090,000
-36.2%
490,549
-9.1%
0.02%
-33.3%
Q2 2021$89,518,000
+25.6%
539,943
+5.7%
0.03%
+17.4%
Q1 2021$71,271,000
-15.5%
510,896
+4.8%
0.02%
-20.7%
Q4 2020$84,361,000
+50.4%
487,357
+21.1%
0.03%
+31.8%
Q3 2020$56,083,000
+24.4%
402,605
+6.7%
0.02%
+22.2%
Q2 2020$45,089,000
+98.9%
377,407
+66.4%
0.02%
+63.6%
Q1 2020$22,671,000
-30.4%
226,754
-18.2%
0.01%
-8.3%
Q4 2019$32,583,000
+81.2%
277,206
+32.5%
0.01%
+71.4%
Q3 2019$17,980,000
-33.0%
209,137
-49.4%
0.01%
-36.4%
Q2 2019$26,818,000
+2696.5%
413,667
+2878.6%
0.01%
+83.3%
Q4 2017$959,000
-90.9%
13,888
-88.0%
0.01%
-91.3%
Q3 2017$10,520,000
+698.8%
115,752
+554.0%
0.07%
+762.5%
Q2 2017$1,317,000
-16.6%
17,700
+5.1%
0.01%
-11.1%
Q1 2017$1,579,000
+26.6%
16,847
-1.8%
0.01%
+50.0%
Q4 2016$1,247,000
+2.9%
17,159
+47.7%
0.01%
-14.3%
Q3 2016$1,212,000
-3.0%
11,615
-31.4%
0.01%
-12.5%
Q2 2016$1,250,00016,9430.01%
Other shareholders
NEVRO CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders